Margarita Amenedo

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study

Emilio Alba, Miguel Martín, Manuel Ramos et al. · Journal of Clinical Oncology · 2004 · 128 citations · Full text

Medicine, Oncology, Pharmacology +16

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

Jonathan A. Ledermann, Amit M. Oza, Domenica Lorusso et al. · The Lancet Oncology · 2020 · 127 citations · Full text

Medicine, Oncology, Pharmacology +15

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience

Ma Carmen Areses Manrique, Joaquín Mosquera, Jorge García et al. · Translational Lung Cancer Research · 2018 · 63 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

Juan Ruiz‐Bañobre, María C. Areses-Manrique, Joaquín Mosquera et al. · Translational Lung Cancer Research · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +17